PortfoliosLab logo
Aspira Women's Health Inc. (AWH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US04537Y1091

CUSIP

04537Y109

IPO Date

Jun 27, 1996

Highlights

Market Cap

$2.89M

EPS (TTM)

-$0.93

Total Revenue (TTM)

$7.03M

Gross Profit (TTM)

$4.27M

EBITDA (TTM)

-$12.69M

Year Range

$0.02 - $3.18

Target Price

$5.50

Short %

1.77%

Short Ratio

0.02

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

Returns By Period

Aspira Women's Health Inc. (AWH) returned -96.17% year-to-date (YTD) and -99.09% over the past 12 months. Over the past 10 years, AWH returned -50.27% annually, underperforming the S&P 500 benchmark at 10.46%.


AWH

YTD

-96.17%

1M

-71.49%

6M

-96.86%

1Y

-99.09%

5Y*

-75.90%

10Y*

-50.27%

^GSPC (Benchmark)

YTD

-3.77%

1M

7.44%

6M

-5.60%

1Y

8.37%

5Y*

14.12%

10Y*

10.46%

*Annualized

Monthly Returns

The table below presents the monthly returns of AWH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-46.51%-56.09%-43.30%-71.25%-96.17%
202432.35%-26.85%-21.52%3.87%-23.29%-39.68%-12.75%-20.77%-21.36%11.11%-1.11%-20.79%-82.72%
202349.16%-24.05%-2.87%-4.78%-38.59%3.12%-22.96%78.82%17.54%-11.94%-32.63%28.30%-18.22%
2022-31.64%-9.92%-4.59%-38.81%-7.29%-0.42%34.42%-35.42%-27.02%5.83%-8.10%-8.12%-81.21%
202132.94%-22.31%-2.60%-15.26%-2.27%0.54%-20.28%-14.96%-14.70%3.08%-37.91%-14.90%-73.62%
2020-3.91%1.50%5.37%86.21%110.97%17.43%16.41%-35.91%7.68%22.20%28.91%38.07%728.40%
2019153.37%-1.33%53.33%8.70%-12.00%-19.09%-18.97%-28.66%1.56%21.24%23.91%3.18%170.00%
2018-22.28%-0.00%-9.33%-0.74%-23.70%-24.22%-25.02%7.66%12.70%-29.58%8.48%-44.69%-84.46%
201730.53%86.29%-9.52%-9.57%-9.52%7.60%-18.48%-15.33%41.73%-18.37%16.37%12.87%103.16%
2016-15.01%5.89%-9.26%-5.44%-11.51%-9.76%23.42%2.92%-7.80%-25.38%23.72%-20.84%-47.22%
2015-11.56%5.68%-4.84%1.69%14.44%0.49%-3.38%2.00%-1.96%-2.00%-8.67%0.56%-9.55%
201413.14%27.34%-13.24%8.81%-15.73%-4.62%-13.95%-0.90%-18.64%-10.61%-1.25%25.95%-15.68%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AWH is 5, meaning it’s performing worse than 95% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AWH is 55
Overall Rank
The Sharpe Ratio Rank of AWH is 1111
Sharpe Ratio Rank
The Sortino Ratio Rank of AWH is 00
Sortino Ratio Rank
The Omega Ratio Rank of AWH is 11
Omega Ratio Rank
The Calmar Ratio Rank of AWH is 11
Calmar Ratio Rank
The Martin Ratio Rank of AWH is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Aspira Women's Health Inc. (AWH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Aspira Women's Health Inc. Sharpe ratios as of May 11, 2025 (values are recalculated daily):

  • 1-Year: -0.78
  • 5-Year: -0.66
  • 10-Year: -0.52
  • All Time: -0.07

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Aspira Women's Health Inc. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Loading data...

Dividends

Dividend History


Aspira Women's Health Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Aspira Women's Health Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aspira Women's Health Inc. was 100.00%, occurring on Apr 17, 2025. The portfolio has not yet recovered.

The current Aspira Women's Health Inc. drawdown is 100.00%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-100%Nov 8, 20006120Apr 17, 2025
-25.04%Oct 3, 200012Oct 18, 200014Nov 7, 200026

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aspira Women's Health Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Aspira Women's Health Inc., comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 61.4% positive surprise.


-10.00-8.00-6.00-4.00-2.000.00AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
-0.09
-0.22
Actual
Estimate

Valuation

The Valuation section provides an overview of how Aspira Women's Health Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for AWH compared to other companies in the Diagnostics & Research industry. AWH currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AWH relative to other companies in the Diagnostics & Research industry. Currently, AWH has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AWH in comparison with other companies in the Diagnostics & Research industry. Currently, AWH has a P/B value of 5.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items